Yao-Gui Wu

Dr. Yao-Gui Wu

Department of Oncology, Renmin Hospital of Wuhan University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WZWen-Bin Zhang
Wen-Bin Zhang
YZYong-Fa Zheng
Yong-Fa Zheng
YWYao-Gui Wu
Yao-Gui Wu
Doxorubicin‐ (DOX‐) related cardiac injury impairs the life quality of patients with cancer. This largely limited the clinical use of DOX. It is of great significance to find a novel strategy to reduce DOX‐related cardiac injury. Oroxylin A (OA) has been identified to exert beneficial effects against inflammatory diseases and cancers. Here, we investigated whether OA could attenuate DOX‐induced acute cardiotoxicity in mice. A single dose of DOX was used to induce acute cardiac injury in mice. To explore the protective effects, OA was administered to mice for ten days beginning from five days before DOX injection. The data in our study indicated that OA inhibited DOX‐induced heart weight loss, reduction in cardiac function, and the elevation in myocardial injury markers. DOX injection resulted in increased oxidative damage, inflammation accumulation, and myocardial apoptosis in vivo and in vitro, and these pathological alterations were alleviated by treatment of OA. OA activated the sirtuin 1 (Sirt1) signaling pathway via the cAMP/protein kinase A, and its protective effects were blocked by Sirt1 deficiency. OA treatment did not affect the tumor‐killing action of DOX in tumor‐bearing mice. In conclusion, OA protected against DOX‐related acute cardiac injury via the regulation of Sirt1.

20 April 2021 in PPAR Research
Verified
Journal Article
Open access
PDF file
WZWen-Bin Zhang
Wen-Bin Zhang
YZYong-Fa Zheng
Yong-Fa Zheng
YWYao-Gui Wu
Yao-Gui Wu
Background. The clinical usefulness of doxorubicin (DOX), an anthracycline with antitumor activity, is limited by its cardiotoxicity. Oxidative stress and myocardial apoptosis were closely associated with DOX-induced cardiac dysfunction. It has been reported that microRNA-128-3p (miR-128-3p) was involved into the regulation of redox balance. However, the role of miR-128-3p in DOX-related cardiac injury remains not yet understood. The aim of this study was to investigate the biological effect of miR-128-3p in DOX-induced cardiotoxicity. Methods. To induce DOX-related acute cardiac injury, mice were subjected to a single injection of DOX. Inhibition of myocardial miR-128-3p was achieved by an adeno-associated virus (AAV9) system carrying a miR-128-3p sponge. Results. The data in our study indicated that miR-128-3p was upregulated in DOX-treated hearts and cardiomyocytes. Inhibition of miR-128-3p attenuated DOX-related cardiac injury and improved cardiac function in mice. Moreover, miR-128-3p inhibition could suppress myocardial inflammatory response, oxidative damage, and cell apoptotic death in DOX-treated mice. Further analysis showed that miR-128-3p could directly target peroxisome proliferator-activated receptor γ (PPAR-γ) and decrease PPAR-γ expression. Moreover, the protective effects provided by miR-128-3p inhibition were abolished by a PPAR-γ antagonist in vivo and in vitro. Conclusions. miR-128-3p inhibition attenuated DOX-related acute cardiac injury via the regulation of PPAR-γ in mice.

1 July 2018 in JAMA Oncology
Verified
Journal Article
Closed access
PDF file
YCYanlei Cheng
Yanlei Cheng
YWYao-Gui Wu
Yao-Gui Wu
LWLong Wu
Long Wu
To the Editor Based on a retrospective study, Haratani et al recently revealed that the occurrence of immune-related adverse events (irAEs) could potentially pr

27 December 2013 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
RMRuo-Lan Ma
Ruo-Lan Ma
LMLi Min
Li Min
DCDuo Chen
Duo Chen
WTWei-Ping Tao
Wei-Ping Tao
WGWei Ge
Wei Ge
YWYao-Gui Wu
Yao-Gui Wu
N-acetyltransferase 2 (NAT2) gene encodes a phase II enzyme taking part in detoxification of aromatic amines. Published studies have demonstrated that N-Acetyltransferase 2 (NAT2) phenotype is a risk factor of various cancers. Many studies have inves